about
Surgical technology and pharmacology of hyperthermic perioperative chemotherapyTargeted methylation of the epithelial cell adhesion molecule (EpCAM) promoter to silence its expression in ovarian cancer cellsBone marrow stromal antigen 2 expressed in cancer cells promotes mammary tumor growth and metastasis.Peritoneal tumor spread in serous ovarian cancer-epithelial mesenchymal status and outcomeTargeting signaling pathways in epithelial ovarian cancer.Therapeutic application of monoclonal antibodies in cancer: advances and challenges.Correlation between overexpression of EpCAM in prostate tissues and genesis of androgen-dependent prostate cancer.Bi-specific and tri-specific antibodies- the next big thing in solid tumor therapeutics
P2860
Q26768405-6F30B3D0-4178-4A31-9AFE-115BBB33FDE4Q31149698-D6C2B396-B2DA-4200-BA5A-6D6A7552D957Q35021021-9C06D856-87D3-4A97-ABCB-AADED35721B1Q36232027-BFF81992-4170-4545-A345-625233005B94Q36913614-741C81BD-F49D-465C-AD82-DA393EDB1F19Q38057179-B8D2FF49-A5F5-4228-BDEC-0CD4EA891898Q39007259-604A9944-6BEC-428D-AC49-582CC6D48215Q57151874-89487F93-153E-4ED8-825F-9E0EA8355AB4
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Catumaxomab: in malignant ascites.
@en
type
label
Catumaxomab: in malignant ascites.
@en
prefLabel
Catumaxomab: in malignant ascites.
@en
P2860
P1433
P1476
Catumaxomab: in malignant ascites.
@en
P2093
James E Frampton
P2860
P304
P356
10.2165/11209040-000000000-00000
P577
2012-07-01T00:00:00Z
P6179
1036931797